Results 191 to 200 of about 115,023 (299)

Inflammatory Bowel Disease in Patients With Atopic Dermatitis and Allergic Rhinitis: A Nationwide Case-Control Study. [PDF]

Int J Rheum Dis
Tseng CF, Wu MC, Wang YH, Huang JY, Lin HC, Tseng TC, Yeh CJ, Wei JC.   +7 more
europepmc   +1 more source

Elevated CO2 and Temperature Alter Grass Pollen's Ability to Modify Transcriptome and Function of the Nasal Epithelium

Allergy, EarlyView.
We exposed human nasal epithelial tissues to pollen from grasses grown under different climate treatments (temperature and CO2). Pollen weakened epithelial tight junctions and altered cytokine‐related gene expression, with similar protein‐level effects.
Tarleena Tossavainen, Tanja Turunen, Maria‐Viola Martikainen, Miisa Kankaanpää, Marjo Malinen, Marjut Roponen   +5 more
wiley   +1 more source

Interplay and severity of nasal and ocular symptoms in allergic rhinitis. [PDF]

J Family Med Prim Care
Al-Surayhi MM, Fageeh YA.
europepmc   +1 more source

Burden of allergic rhinitis in the United Kingdom. [PDF]

Front Allergy
Jones M, Shepherd H, Hatziioanou D, Martin D, Mutafya C, Bohman U, Hodgson S, Williams R.   +7 more
europepmc   +1 more source

Prevalence of Allergic Rhinitis in China Continues to Increase Without Reaching a Plateau: An Analysis of Three Waves of National Surveys From 2005 to 2019

Allergy, EarlyView.
Xiaoyu Pu, Ming Zheng, Siqi Ge, Yutong Sima, Xiaoru Yu, Zhongyi Wang, Xiangdong Wang, Luo Zhang   +7 more
wiley   +1 more source

Integrated Clinical Trial and Molecular Profiling Reveals Immune Drivers of Chronic Hand Eczema

Allergy, EarlyView.
This study performed an unbiased molecular profiling of CHE patients across diverse etiologies to identify shared pathogenic drivers and evaluate the impact of IL‐4Rα blockade via dupilumab over 16 weeks. CHE shows a mixed immune signature involving type 1, 2, and 3 pathways with features of atopic dermatitis and psoriasis.
Perrine Gery, Rüçhan Ekren, Emilie Bérard, Aurélie Du‐Thanh, Hugo Rimet, Fatma Jendoubi, Vanina Lenief, Nadia Raison‐Peyron, Amel Bouznad, Maria P. Konstantinou, Jonathan Rioual, Lilian Basso, Juliette Mouiren, Manon Boussier, Brigitte Milpied, Cristina Bulai Livideanu, Louise Jaulent, Florence Hacard, Marine A. Lefevre, Audrey Nosbaum, Julien Seneschal, Marc Vocanson, Carle Paul, Nicolas Gaudenzio, Marie Tauber, on behalf of the French Atopic Dermatitis Network from de GREAT Research group   +25 more
wiley   +1 more source

Role of Periostin in the Development of Nasal Hyperresponsiveness in Mice with Allergic Rhinitis. [PDF]

Int J Mol Sci
Adachi Y, Ando Y, Nagaosa K, Maeno M, Yamashita M, Takenoya F, Shioda S, Hanazaki M, Sakai H, Chiba Y.   +9 more
europepmc   +1 more source

Circulating Type 2 Memory B Cell Frequency Is a Biomarker for Allergen Immunotherapy Efficacy in Patients With Allergic Rhinitis

Allergy, EarlyView.
Yue Ma, Shuying Li, Lei Ye, Lin Qiu, Jiayu Wu, Jiaying Li, Xian Feng, Wei Qian, Xiangping Yang, Huabin Li, Hongfei Lou   +10 more
wiley   +1 more source

A One‐Strength Dose Escalation Regimen for Birch Pollen SCIT Is Safe and Tolerable in Children, Adolescents, and Adults

Allergy, EarlyView.
This study evaluated safety and tolerability of birch pollen SCIT during dose escalation with a new One‐Strength regimen (3 injections, Strength B) compared to the Standard regimen (7 injections, Strengths A and B) in patients aged 5–65 years. Safety and tolerability were comparable between the two regimens in adults, adolescents, and adolescents, as ...
Marek Jutel, Ludger Klimek, Michael Gerstlauer, Dana Troyke, Kristina Duwensee, Christian Vogelberg   +5 more
wiley   +1 more source

Nanoparticle-Based Targeted Drug Delivery Systems for Allergic Rhinitis: A Comprehensive Review. [PDF]

Int J Nanomedicine
Wang Y, Zhou Y, Liang B, Li S, Wang Z, Yan X, Gao Y, Li T, Qin Q, Yang S, Guo F, Nie J.   +11 more
europepmc   +1 more source